Transient ischemic cerebral lesions during induction chemotherapy for acute lymphoblastic leukemia

H Pihko1, T Tyni, K Virkola

  • 1Department of Child Neurology, Children's Hospital, University of Helsinki, Finland.

The Journal of Pediatrics
|November 1, 1993
PubMed

Insights

Nine children undergoing chemotherapy for leukemia or lymphoma experienced neurological symptoms like hallucinations and seizures. These stroke-like, but reversible, white matter lesions were linked to vascular ischemia.

Area of Science:

  • Pediatric Oncology
  • Pediatric Neurology
  • Vascular Neurology

Background:

  • Acute lymphoblastic leukemia and non-Hodgkin lymphoma are common childhood cancers.
  • Induction chemotherapy is a critical phase in treating these hematologic malignancies.
  • Neurological complications can arise during cancer treatment, impacting patient outcomes.

Purpose of the Study:

  • To investigate neurological complications observed during induction chemotherapy in children with leukemia or lymphoma.
  • To characterize the clinical presentation, neuroradiologic findings, and potential etiology of these neurological events.

Main Methods:

  • Retrospective review of medical records for 90 children treated between 1986-1992.
  • Detailed analysis of clinical symptoms, including visual hallucinations, confusion, seizures, constipation, and hypertension.
  • Neuroradiologic examination (e.g., MRI, CT) to identify brain lesions.

Main Results:

  • Nine children (10%) developed neurological symptoms during induction chemotherapy.
  • Symptoms included visual hallucinations, confusion, and seizures, often preceded by constipation and hypertension.
  • Neuroradiologic findings revealed bilateral cortical/subcortical white matter lesions, suggestive of vascular ischemia in arterial watershed areas. These lesions were reversible.

Conclusions:

  • A subset of children undergoing chemotherapy for leukemia or lymphoma may experience reversible, stroke-like neurological complications.
  • Vascular ischemia in the cerebral arterial watershed areas is a likely cause of these neurological manifestations.
  • Prompt recognition and further investigation of these symptoms are crucial for managing pediatric cancer patients.